Understanding the Implications of COVID-19 for Patients with Inflammatory Rheumatic Diseases
Understanding the Implications of COVID-19 for Patients with Inflammatory Rheumatic Diseases
Developed by CESAS Medical, under the auspices of the University of Glasgow. This activity is supported by AbbVie and Lilly.
Release date: 21 May 2020
Estimated time to complete activity: 1hr 30min
Compatible with all modern internet browsers and mobile devices
EDUCATIONAL OBJECTIVES
After completing this activity, the learner will:
Describe the nature of the virus and its similarities and differences to other SARS viruses and other viral infections
Understand the options and strategies for managing patients during the pandemic
Understand the options and strategies for management of patients who have contracted COVID-19
Understand the important role of the COVID-19 registries worldwide
TARGET AUDIENCE
This activity is designed for qualified rheumatologists of all levels of seniority, and other healthcare professionals involved in treating patients with inflammatory disease.
PROGRAMME OVERVIEW
The global COVID-19 pandemic has caused much concern in the rheumatology community and has highlighted an educational need to guide rheumatologists in the best practices for managing patients during this uncertain time. This online educational course, Understanding the Implications of COVID-19 for Patients with Inflammatory Rheumatic Diseases, aims to discuss the important questions raised by the pandemic.
In this activity, Understanding the Implications of COVID-19 for Patients with Inflammatory Rheumatic Diseases, international experts will discuss some of the important considerations for rheumatologists when managing patients in the COVID-19 pandemic. The course content will focus on the management of patients with rheumatoid arthritis, with and without COVID-19, in addition to highlighting the importance of inputting data into COVID-19 rheumatology registries during this time.
INSTRUCTIONS FOR PARTICIPATION
Participants must 1) read the activity information; 2) study the educational activity; 3) successfully complete the post-module assessments with a score of 80% or better; 4) and complete the evaluation form. Upon completion of the full activity, your certificate will be made available to download and print.
DISCLOSURE OF CONFLICTS OF INTEREST
CESAS Medical requires faculty, presenters, planners, managers, writers, and any other individuals who are in a position to influence the content of this activity to disclose any real and/or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly reviewed and resolved according to CESAS Medical policy.
ACCREDITATION STATEMENT
The e-learning activity, Understanding the Implications of COVID-19 for Patients with Inflammatory Rheumatic Diseases, organised by CESAS Medical, under the auspices of the University of Glasgow, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The e-learning activity, Understanding the Implications of COVID-19 for Patients with Inflammatory Rheumatic Diseases, organised by CESAS Medical, under the auspices of the University of Glasgow, is awarded 1 European CME credits (ECMECs).
Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited. Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.